FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1865725105> ?p ?o ?g. }

• W1865725105 endingPage "131" @default.
• W1865725105 startingPage "131" @default.
• W1865725105 abstract "PURPOSE: Although several new chemotherapeutic agents are promising as primary therapy in non-small–cell lung cancer (NSCLC), few have demonstrated activity in platinum-refractory disease. Based on encouraging results reported in two single-institution studies of docetaxel in this setting, we performed a multicenter phase II trial evaluating this novel taxane in previously treated NSCLC patients prospectively categorized by platinum response status. PATIENTS AND METHODS: Eighty patients with NSCLC previously treated with platinum-based chemotherapy received docetaxel at a dose of 100 mg/m 2 intravenously over 1 hour, repeated every 21 days, accompanied by dexamethasone 8 mg orally twice daily for 5 days. Forty-seven patients (59%) were defined as platinum-refractory based on response status to prior therapy. RESULTS: The median number of cycles delivered per patient was four (range, one to 21 cycles). Partial response was observed in 13 (16%) of 80 of patients, with similar response rates in platinum-sensitive and platinum-refractory patients. The median survival time was 7 months, and the 1-year survival rate was 25%. Docetaxel was relatively well tolerated in this previously treated population. Grade IV neutropenia was common in patients (77%) but typically of brief duration. Febrile neutropenia was observed in 11 patients (14%), with no fatal infections. Severe fluid retention was rare (4% of patients). CONCLUSIONS: This multicenter phase II trial confirms antitumor activity and encouraging survival with docetaxel therapy in platinum-treated and platinum-refractory NSCLC. To validate these results, a phase III trial randomizing platinum-treated patients to docetaxel or best supportive care is underway." @default.
• W1865725105 created "2016-06-24" @default.
• W1865725105 creator A5008786567 @default.
• W1865725105 creator A5015680000 @default.
• W1865725105 creator A5016620187 @default.
• W1865725105 creator A5036091074 @default.
• W1865725105 creator A5050073720 @default.
• W1865725105 creator A5059652753 @default.
• W1865725105 creator A5063904421 @default.
• W1865725105 creator A5066247071 @default.
• W1865725105 creator A5078648580 @default.
• W1865725105 date "2000-01-01" @default.
• W1865725105 modified "2023-09-27" @default.
• W1865725105 title "Activity of Docetaxel in Platinum-Treated Non–Small-Cell Lung Cancer: Results of a Phase II Multicenter Trial" @default.
• W1865725105 cites W1837121308 @default.
• W1865725105 cites W1883066466 @default.
• W1865725105 cites W1919092210 @default.
• W1865725105 cites W1922104747 @default.
• W1865725105 cites W1934698255 @default.
• W1865725105 cites W2014145691 @default.
• W1865725105 cites W2020691687 @default.
• W1865725105 cites W2104325484 @default.
• W1865725105 cites W2107290371 @default.
• W1865725105 cites W2129793485 @default.
• W1865725105 cites W2131928292 @default.
• W1865725105 cites W2167395325 @default.
• W1865725105 cites W2317448174 @default.
• W1865725105 cites W4239714259 @default.
• W1865725105 doi "https://doi.org/10.1200/jco.2000.18.1.131" @default.
• W1865725105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10623703" @default.
• W1865725105 hasPublicationYear "2000" @default.
• W1865725105 type Work @default.
• W1865725105 sameAs 1865725105 @default.
• W1865725105 citedByCount "131" @default.
• W1865725105 countsByYear W18657251052012 @default.
• W1865725105 countsByYear W18657251052013 @default.
• W1865725105 countsByYear W18657251052014 @default.
• W1865725105 countsByYear W18657251052015 @default.
• W1865725105 countsByYear W18657251052016 @default.
• W1865725105 countsByYear W18657251052017 @default.
• W1865725105 crossrefType "journal-article" @default.
• W1865725105 hasAuthorship W1865725105A5008786567 @default.
• W1865725105 hasAuthorship W1865725105A5015680000 @default.
• W1865725105 hasAuthorship W1865725105A5016620187 @default.
• W1865725105 hasAuthorship W1865725105A5036091074 @default.
• W1865725105 hasAuthorship W1865725105A5050073720 @default.
• W1865725105 hasAuthorship W1865725105A5059652753 @default.
• W1865725105 hasAuthorship W1865725105A5063904421 @default.
• W1865725105 hasAuthorship W1865725105A5066247071 @default.
• W1865725105 hasAuthorship W1865725105A5078648580 @default.
• W1865725105 hasConcept C121332964 @default.
• W1865725105 hasConcept C121608353 @default.
• W1865725105 hasConcept C126322002 @default.
• W1865725105 hasConcept C141071460 @default.
• W1865725105 hasConcept C142424586 @default.
• W1865725105 hasConcept C143998085 @default.
• W1865725105 hasConcept C2776256026 @default.
• W1865725105 hasConcept C2776694085 @default.
• W1865725105 hasConcept C2777063308 @default.
• W1865725105 hasConcept C2777511904 @default.
• W1865725105 hasConcept C2778850193 @default.
• W1865725105 hasConcept C2781190966 @default.
• W1865725105 hasConcept C31760486 @default.
• W1865725105 hasConcept C530470458 @default.
• W1865725105 hasConcept C71924100 @default.
• W1865725105 hasConcept C87355193 @default.
• W1865725105 hasConcept C90924648 @default.
• W1865725105 hasConceptScore W1865725105C121332964 @default.
• W1865725105 hasConceptScore W1865725105C121608353 @default.
• W1865725105 hasConceptScore W1865725105C126322002 @default.
• W1865725105 hasConceptScore W1865725105C141071460 @default.
• W1865725105 hasConceptScore W1865725105C142424586 @default.
• W1865725105 hasConceptScore W1865725105C143998085 @default.
• W1865725105 hasConceptScore W1865725105C2776256026 @default.
• W1865725105 hasConceptScore W1865725105C2776694085 @default.
• W1865725105 hasConceptScore W1865725105C2777063308 @default.
• W1865725105 hasConceptScore W1865725105C2777511904 @default.
• W1865725105 hasConceptScore W1865725105C2778850193 @default.
• W1865725105 hasConceptScore W1865725105C2781190966 @default.
• W1865725105 hasConceptScore W1865725105C31760486 @default.
• W1865725105 hasConceptScore W1865725105C530470458 @default.
• W1865725105 hasConceptScore W1865725105C71924100 @default.
• W1865725105 hasConceptScore W1865725105C87355193 @default.
• W1865725105 hasConceptScore W1865725105C90924648 @default.
• W1865725105 hasIssue "1" @default.
• W1865725105 hasLocation W18657251051 @default.
• W1865725105 hasLocation W18657251052 @default.
• W1865725105 hasOpenAccess W1865725105 @default.
• W1865725105 hasPrimaryLocation W18657251051 @default.
• W1865725105 hasRelatedWork W1865725105 @default.
• W1865725105 hasRelatedWork W1953045401 @default.
• W1865725105 hasRelatedWork W1968954703 @default.
• W1865725105 hasRelatedWork W2015699114 @default.
• W1865725105 hasRelatedWork W2046284161 @default.
• W1865725105 hasRelatedWork W2106964779 @default.
• W1865725105 hasRelatedWork W2109022672 @default.
• W1865725105 hasRelatedWork W2111487955 @default.
• W1865725105 hasRelatedWork W4235400347 @default.

• next